KalVista Pharmaceuticals
Latest round
- Series B
Last raised
- Jul 2015
Total raised
- $46M
Investors
- 5
About KalVista Pharmaceuticals
Founded in 2011 and based in Massachusetts, US, KalVista Pharmaceuticals, Inc. is a biotechnology company that focuses on developing pharmaceuticals based on small molecule protease and plasma kallikrein inhibitors to provide prophylactic therapeutics. In June 2016, KalVista Pharmaceuticals, Inc. merged with Carbylan Therapeutics, Inc. to operate as KalVista Pharmaceuticals, Inc. Following the merger, the company became publicly listed on the Nasdaq under the ticker symbol KALV. The company's R&D team provides protease and plasma kallikrein inhibitors with multiple small molecules to treat diabetes-related blindness by reducing retinal vessel leakage and suppressing the excessive bradykinin production for patients with acute HAE (hereditary angioedema) and DME (diabetic macular edema). The company's drug candidates portfolio includes KVD900, KVD824, KVD001, Factor XIIa, and Oral DME Molecules. KalVista Pharmaceuticals, Inc.13 million in FY 2019. KalVista Pharmaceuticals, Inc. plans to fund the planned Phase 3 trial of KVD900, Phase 2 trial of KVD824, and the continued development of Factor XIIa programs following the February 2021 public offering.
Who invested in KalVista Pharmaceuticals
5 investors across 2 rounds
See all investors in KalVista Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KalVista Pharmaceuticals
Who invested in KalVista Pharmaceuticals?
KalVista Pharmaceuticals has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KalVista Pharmaceuticals raised?
KalVista Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did KalVista Pharmaceuticals last raise money?
KalVista Pharmaceuticals's most recent round on record is a Series B, in Jul 2015.
What does KalVista Pharmaceuticals do?
Founded in 2011 and based in Massachusetts, US, KalVista Pharmaceuticals, Inc.
Where is KalVista Pharmaceuticals headquartered?
KalVista Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like KalVista Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at KalVista Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like KalVista Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.